Khiron Life Sciences(OTC) KHRNF

Market CapN/A

Since IPO (2018)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0.00%

+0.00Today

Khiron Life Sciences last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-27

Khiron Life Sciences stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-08-20
1 month	+0%	USD 0.00	2026-07-28
3 month	+0%	USD 0.00	2026-05-22
Year to date	+0%	USD 0.00	2025-12-31
1 year	+0%	USD 0.00	2025-08-26
3 year	-99.99%	USD 0.01	2023-08-28
5 year	-100%	USD 0.23	2021-08-27
Since inception	-100%	USD 0.84	2018-05-29

Khiron Life Sciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$16.14M

Net Income (TTM)

-CA$30.66M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

664.28 (High)

Dividend

$0.00

Beta (Volatility)

664.28 (High)

Price

$0.00

Volume

200

Open

$0.00

Price

$0.00

Volume

200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 31, 2026

Dividend

$0.00

Beta (Volatility)

664.28 (High)

Price

$0.00

Volume

200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 31, 2026

KHRNF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Khiron Life Sciences

Khiron Life Sciences Corp. operates as a comprehensive medical and cannabis enterprise, extending its operations across Latin America and Europe. The company focuses on the end-to-end process of medical cannabis, including cultivation, manufacturing, distribution, and international export of THC and CBD products.

Products and Services

Health services through a network of clinics under ILANS and Zerenia brands
Medical cannabis products, including THC and CBD varieties
Wellbeing products, such as CBD-based cosmeceuticals marketed under the Kuida brand

Growth Outlook

Expansion into European markets is underway, enhancing international presence
Increasing demand for medical cannabis products supports revenue growth potential
Strategic partnerships are being developed to enhance distribution capabilities

Financial Highlights

Recent quarterly revenue of CAD 3.39 million shows a solid market position
Trailing twelve months (TTM) gross profit margin stands at 22.5%, indicating operational efficiency
Current ratio of 3.08 suggests strong liquidity and financial health

Khiron Life Sciences Corp. is positioned in the rapidly growing cannabis industry, with a focus on medical applications. The company's diverse product offerings and strategic expansion plans highlight its commitment to capturing market share in both Latin America and Europe. Recent financial performance indicates a solid foundation, with a notable gross profit margin and a strong liquidity position. As the demand for medical cannabis continues to rise, Khiron's innovative approach and operational strategies may provide significant opportunities for growth and investor interest.

AI Generated • Aug 8, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

310

CEO

Álvaro F. Torres, MBA

Website

www.khiron.ca

Headquarters

Vancouver, BC V6C 2B5, CA

KHRNF Financials

Key Financial Metrics (TTM)

Gross Margin

22.47%

Operating Margin

-174.52%

Net Income Margin

-258.92%

Return on Equity

-68.62%

Return on Capital

-55.65%

Return on Assets

-78.37%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

200

Avg. Volume

6.15K

Financials (TTM)

Gross Profit

CA$6.67M

Operating Income

-CA$14.55M

EBITDA

-CA$12.97M

Operating Cash Flow

-CA$15.01M

Capital Expenditure

-CA$2.78M

Free Cash Flow

-CA$17.80M

Cash & ST Invst.

CA$1.94M

Total Debt

CA$2.56M

Khiron Life Sciences Performance Analysis

Khiron Life Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	CAD 10,205,525	N/A

Khiron Life Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2021-12-31	3.3%
Q1	2022-03-31	27.7%
Q2	2022-06-30	-3.7%
Q3	2022-09-30	-24.3%

Khiron Life Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	CAD -0.16	N/A

Khiron Life Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2021-12-31	-482.0%
Q1	2022-03-31	72.5%
Q2	2022-06-30	61.6%
Q3	2022-09-30	-44.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2022YOY CHG

Revenue

CA$3.39M

-3.8%

Gross Profit

CA$1.65M

-8.8%

Gross Margin

48.83%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

310

N/A

Net Income

-CA$3.58M

-7.2%

EBITDA

-CA$2.89M

+32.3%

Quarterly Fundamentals

Name

Q3 2022YOY CHG

Total Cash

CA$1.94M

-87.4%

Total Debt

CA$2.56M

+32.6%

Accounts Receivable

CA$4.38M

+7.3%

Inventory

CA$9.81M

-1.3%

Long Term Debt

CA$1.34M

N/A

Short Term Debt

CA$1.23M

+290.3%

Return on Assets

-78.37%

N/A

Return on Invested Capital

-64.62%

N/A

Free Cash Flow

-CA$5.92M

-16.8%

Operating Cash Flow

-CA$5.04M

-3.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

KAYSKaya Holdings, Inc.

KAYSKaya Holdings, Inc.$0.00+0.00%

EVIOEVIO, Inc.

EVIOEVIO, Inc.$0.00+0.00%

SHMNSOHM, Inc.

SHMNSOHM, Inc.$0.00+0.00%

HEMPHemp, Inc

HEMPHemp, Inc$0.00+0.00%

BSPKBespoke Extracts, Inc.

BSPKBespoke Extracts, Inc.$0.00+0.00%

PBFFFPlanet Based Foods Global Inc.

PBFFFPlanet Based Foods Global Inc.$0.01+0.00%

KOANResonate Blends, Inc.

KOANResonate Blends, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

QNRXQuoin Pharmaceuticals

QNRXQuoin Pharmaceuticals$7.89+0.53%

NVDANvidia

NVDANvidia$228.55+0.00%

IRENIren

IRENIren$37.87-0.07%

PYPLPayPal

PYPLPayPal$53.63-0.13%

MRVLMarvell Technology

MRVLMarvell Technology$227.43-0.06%

INTCIntel

INTCIntel$92.43+0.00%

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF$46.31+0.02%

Questions About KHRNF

What is the current price of Khiron Life Sciences?

Khiron Life Sciences is trading at $0.00 per share.

What is the 52-week range for Khiron Life Sciences?

Over the past 52 weeks, Khiron Life Sciences has traded between $0.00 and $0.00.

How much debt does Khiron Life Sciences have?

As of the most recent reporting period, Khiron Life Sciences reported total debt of CA$1.76M.

How much cash does Khiron Life Sciences have on hand?

Khiron Life Sciences reported CA$7.06M in cash and cash equivalents in its most recent financial results.

What is Khiron Life Sciences’s dividend yield?

Khiron Life Sciences does not currently have a dividend yield.

Khiron Life Sciences(OTC) KHRNF

Khiron Life Sciences Financials at a Glance

KHRNF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Khiron Life Sciences

KHRNF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Khiron Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KHRNF

What is the current price of Khiron Life Sciences?

What is the 52-week range for Khiron Life Sciences?

How much debt does Khiron Life Sciences have?

How much cash does Khiron Life Sciences have on hand?

What is Khiron Life Sciences’s dividend yield?

Premium Investing Services